Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis

Surmeet Bedi1, Aparna Vidyasagar, Arjang Djamali

  • 1Department of Medicine, Nephrology Section, University of Wisconsin Madison School of Medicine and Public Health, Madison, WI 53713, USA.

Insights

Epithelial-to-mesenchymal transition (EMT) drives chronic kidney transplant fibrosis. Further research is needed to confirm EMT

Area of Science:

  • Nephrology
  • Transplantation Immunology
  • Cell Biology

Background:

  • Chronic allograft tubular atrophy/interstitial fibrosis (TA/IF) significantly contributes to late kidney allograft loss.
  • Identifying causes and developing targeted treatments for TA/IF are critical for advancing kidney transplantation.
  • Epithelial-to-mesenchymal transition (EMT) is increasingly recognized as a key process in kidney injury, including chronic allograft TA/IF.

Purpose of the Study:

  • To review the molecular and cellular pathways of EMT in the context of chronic allograft tubulointerstitial fibrosis.
  • To examine the roles of alloimmune T cells and oxidative stress in EMT-driven fibrosis.
  • To evaluate the potential of EMT as a marker for disease progression and discuss therapeutic strategies.

Main Methods:

  • Literature review focusing on molecular and cellular mechanisms of EMT in kidney allografts.
  • Analysis of studies investigating the influence of alloimmunity and oxidative stress on EMT.
  • Evaluation of existing data on EMT as a disease marker and therapeutic target.

Main Results:

  • EMT involves tubular epithelial cells transforming into myofibroblasts via loss of cell adhesion, altered gene expression (e.g., E-cadherin, alpha-smooth muscle actin), and extracellular matrix production.
  • Alloimmune T cells and oxidative stress are implicated in promoting EMT in kidney allografts.
  • EMT is demonstrably involved in the pathogenesis of chronic allograft tubulointerstitial fibrosis.

Conclusions:

  • EMT plays a significant role in the development of chronic allograft tubulointerstitial fibrosis.
  • The precise contribution of EMT to allograft fibrogenesis requires further investigation through interventional trials.
  • Additional research is necessary to validate EMT as a reliable surrogate marker for disease progression in kidney transplant recipients.

Related Concept Videos

Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...